Antiretroviral therapy for HIV-infected infants: progress and pitfalls

被引：1

作者：

Fletcher, CV ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, Denver, CO 80262 USA

来源：

AIDS | 2004年 / 18卷 / 02期

关键词：

antiretroviral therapy; HIV-infected infants;

D O I：

10.1097/00002030-200401230-00024

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：325 / 326

页数：2

共 8 条

[1] Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1 [J].

Gortmaker, SL ;

Hughes, M ;

Cervia, J ;

Brady, M ;

Johnson, GM ;

Seage, GR ;

Song, LY ;

Dankner, WM ;

Oleske, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (21) :1522-1528

[2]

GULICK RM, 2003, 2 INT AIDS SOC C HIV

[3] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].

Palella, FJ ;

Delaney, KM ;

Moorman, AC ;

Loveless, MO ;

Fuhrer, J ;

Satten, GA ;

Aschman, DJ ;

Holmberg, SD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860

[4] Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children [J].

Sáez-Llorens, X ;

Violari, A ;

Deetz, CO ;

Rode, BA ;

Gomez, P ;

Handelsman, E ;

Pelton, S ;

Ramilo, O ;

Cahn, P ;

Chadwick, E ;

Allen, U ;

Arpadi, S ;

Castrejón, MM ;

Heuser, RS ;

Kempf, DJ ;

Bertz, RJ ;

Hsu, AF ;

Bernstein, B ;

Renz, CL ;

Sun, E .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (03) :216-223

[5] EDITORIAL COMMENT - THERAPEUTIC ORPHANS [J].

SHIRKEY, H .

JOURNAL OF PEDIATRICS, 1968, 72 (01) :119-+

[6] Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1 [J].

Starr, SE ;

Fletcher, CV ;

Spector, SA ;

Yong, FH ;

Fenton, T ;

Brundage, RC ;

Manion, D ;

Ruiz, NM ;

Gersten, M ;

Becker, M ;

McNamara, J ;

Mofenson, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1874-1881

[7] Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection [J].

Walmsley, S ;

Bernstein, B ;

King, M ;

Arribas, J ;

Beall, G ;

Ruane, P ;

Johnson, M ;

Johnson, D ;

Lalonde, R ;

Japour, A ;

Brun, S ;

Sun, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) :2039-2046

[8]

*WORK GROUP ANT TH, 2003, GUID US ANT AG PED H

← 1 →